Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures

D. Ademhan Tural (Ankara, Turkey), B. Ozsezen (Ankara, Turkey), B. Sunman (Ankara, Turkey), G. Hazirolan (Ankara, Turkey), N. Emiralioglu (Ankara, Turkey), E. Yalcin (Ankara, Turkey), D. Dogru (Ankara, Turkey), U. Ozcelik (Ankara, Turkey), N. Kiper (Ankara, Turkey)

Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Session: Microbiology and antimicrobial strategies in cystic fibrosis
Session type: E-poster session
Number: 687
Disease area: Paediatric lung diseases, Respiratory infections

Congress or journal article abstractE-poster

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Ademhan Tural (Ankara, Turkey), B. Ozsezen (Ankara, Turkey), B. Sunman (Ankara, Turkey), G. Hazirolan (Ankara, Turkey), N. Emiralioglu (Ankara, Turkey), E. Yalcin (Ankara, Turkey), D. Dogru (Ankara, Turkey), U. Ozcelik (Ankara, Turkey), N. Kiper (Ankara, Turkey). Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures. 687

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cystic Fibrosis Patients Eligible for Modulator Drugs: Data from Cystic Fibrosis Registry of Turkey
Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Year: 2019

Bacterial Contamination of Home Nebulizers in Children with Cystic Fibrosis and Clinical Implication on the Number of Pulmonary Exacerbations
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019


Effects of Telerehabilitation on Peripheral Muscle Function in Pediatric Cystic Fibrosis Patients During Covid-19 Pandemic
Source: Virtual Congress 2021 – Physical activity, exercise training and (tele)rehabilitation in respiratory patients
Year: 2021


The Effects Of Respiratory Viruses on The Acute Pulmonary Exacerbations In Cystic Fibrosis Patients
Source: International Congress 2019 – Insights into paediatric bronchology
Year: 2019


Alveolar Macrophages Produced from Resected Lungs of Patients with Pulmonary Tuberculosis
Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Year: 2017

Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


LATE-BREAKING ABSTRACT: Sweetening Antibiotic Treatment for Eradication of Bacteria Biofilm
Source: International Congress 2014 – Cystic fibrosis: assessment and treatment
Year: 2014


Natural Variability of Clinically Measured Lung Clearance Index in Children with Cystic Fibrosis
Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis
Year: 2021



Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019

Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


Characterization of Mesenchymal Stem Cells obtained from human lungs with and without Idiopathic Pulmonary Fibrosis
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Year: 2019

Histopathologic and Molecular Analysis of Idiopathic Pulmonary Fibrosis Lungs from Patients Treated with Pirfenidone or Nintedanib
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018


Microbiome in Cystic Fibrosis Exacerbations
Source: ERS Lung Science Conference 2019
Year: 2019

Nasal Nitric Oxide Sampling In 0-5-year-old Patients With Cystic Fibrosis, Primary Ciliary Dyskinesia and Healthy Controls
Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function
Year: 2021

Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017


Effects of Lumacaftor-Ivacaftor Therapy on CFTR Function in Phe508del Homozygous Patients with Cystic Fibrosis
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018




Phenotypic Analysis of a Ferret Model of Cystic Fibrosis
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009

Does physiotherapy affect Lung Clearance Index in Cystic Fibrosis patients ?
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018

Cystic Fibrosis in Iran
Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Year: 2019

Treatment of Idiopathic Pulmonary Fibrosis
Source: Guideline 2015
Year: 2015